Clinical Trial Update: Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma

View source ↗

Summary

A clinical trial evaluating the combination of transarterial chemoembolization (TACE) with targeted immunotherapy for unresectable hepatocellular carcinoma, usi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Hepatocellular Carcinoma | Status: ENROLLING_BY_INVITATION